Dopamine Enhancement of Fear Extinction Learning in PTSD (1R21MH108753)

NCT02560389 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

103

Enrollment

OTHER

Sponsor class

Conditions

Stress Disorder, Post Traumatic

Interventions

DRUG: Placebo
DRUG: Levodopa

Sponsor

University of Wisconsin, Madison